Should I add ADT to Salvage Radiation at age 76?

Posted by jablakely @jablakely, Mar 13 11:54am

I just turned 76 years old. My prostate was removed 15 years ago (Gleason was 3+4, grade 2) and I had no trouble until my PSA went from 0.3 to 0.7 in the last 18 months. A Pet scan now shows activity limited to the prostate bed only. My urologist and RO recommend 40 sessions of SRT plus 6 months of ADT. I am considering SRT only.

I am a very vigorous 76: before the pet scan results I booked a week long hiking trip for September in a part of the world I love. From what I see of the statistical benefits of adding ADT, it doesn't seem worth spending my 76th year (and perhaps beyond) suffering the fatigue and other ADT side effects. I am seeing something like a 10-15% better chance of avoiding recurrence with ADT, a 3-6% better chance of avoiding metastasis but at my age, virtually no overall survival benefit.

How would I feel if I refused ADT now and suffered recurrence at age 80 or 85? I suspect I would feel grateful that I thoroughly enjoyed a healthy 76th year.

But the fact that I'm asking for advice on this forum is an indication that I realize the gravity of this decision. Any thoughts, brothers?

Interested in more discussions like this? Go to the Prostate Cancer Support Group.

Profile picture for surftohealth88 @surftohealth88

@jeffmarc

Yes, you remembered well Jeff : ).
And yes, my husband will need ADT at least for 6 mos (we were told), regardless of how low PSA is. Even if we decided to have adjuvant immediately post op with uPSA undetectable, my husband was advised to have ADT since he is a high risk patient.

Jump to this post

@surftohealth88 I think those ASCO recommendations about using PSA at the start of salvage radiation as the only factor to determine whether ADT is needed or not need to be further annotated. There are lots of patients like your husband that have adverse factors that justify the use of ADT regardless of what their PSA is at the start of salvage radiation.

REPLY

Perhaps consider going with Orgovyx and see what side effects, if any, occur. You can stop taking Orgovyx if the side effects become problematic. Good luck.

REPLY

Someone else on this forum just shared this with me and I thought you might find it interesting.
Best wishes! ENJOY that hiking trip you have planned!!
Mike
https://ancan.org/playing-the-long-game-does-your-recurrent-advanced-prostate-cancer-need-treating-nci-seminar/

REPLY
Profile picture for jeff Marchi @jeffmarc

One problem is that you’ve waited a little too long before doing radiation. As a result, the American Society of clinical oncology (ASCO) recommends that you have ADT. You could Put it off until you come back from your trip. It may allow the cancer to grow a little bit, But it is an option. One thing is you do not have a higher risk case since you are a 3+4.

When I have my first ADT shot after my cancer came back, following a prostatectomy, I didn’t even notice the side effects And two months later, I had Eight weeks of salvage radiation. It was a six month shot. 2 1/2 years later when I had to go on ADT full-time then I noticed the side effects.

I’m 78 and I’ve been on it for eight years. I have no fatigue at all nothing that would prevent me from really getting out there and doing whatever I want. I walk a mile at high speed twice a day and I go to the gym three days a week to get weight exercises.

Check out the recommendations from ASCO

From Ascopubs about what PSA to do salvage radiation.
≤0.2 ng/mL:
Starting at this level maximizes disease control and long-term survival. Patients treated at PSA < 0.2 ng/mL achieve higher rates of undetectable post-SRT PSA (56-70%) and improved 5-year progression-free survival (62.7-75%).
Delaying SRT beyond PSA ≥0.25 ng/mL increases mortality risk by ~50%.

0.2–0.5 ng/mL:
Still effective, particularly for patients with low-risk features (e.g., Gleason ≤7, slow PSA doubling time). The Journal of Clinical Oncology recommends SRT before PSA exceeds 0.25 ng/mL to preserve curative potential.

0.5–1.0 ng/mL:
Salvage radiation remains beneficial but may require combining with androgen deprivation therapy (ADT) for higher-risk cases.

This article discusses the above;
https://ascopost.com/news/march-2023/psa-level-at-time-of-salvage-radiation-therapy-after-radical-prostatectomy-and-risk-of-all-cause-mortality/

Jump to this post

@jeffmarc Just saw a post on the Inspire forum where a patient with Gleason 4+5 and Decipher 0.98 consulted with Dr. Kishan who was involved in the POSEIDON study the ASCO recommendations about ADT were based on. Dr. Kishan noted that the POSEIDON study pertained to a general post-surgery population (i.e., all Gleason scores), whereas high Gleason scores are important in the decision making for the use of ADT. Also, for that study, men's Decipher scores were unknown and/or not used although high Decipher scores should be considered as well on the need for ADT with salvage radiation. See the complete post here,
https://www.inspire.com/groups/zero-prostate-cancer/discussion/bda128-adt-and-salvage-radiation-after-surgery/

REPLY
Profile picture for wwsmith @wwsmith

@jeffmarc Just saw a post on the Inspire forum where a patient with Gleason 4+5 and Decipher 0.98 consulted with Dr. Kishan who was involved in the POSEIDON study the ASCO recommendations about ADT were based on. Dr. Kishan noted that the POSEIDON study pertained to a general post-surgery population (i.e., all Gleason scores), whereas high Gleason scores are important in the decision making for the use of ADT. Also, for that study, men's Decipher scores were unknown and/or not used although high Decipher scores should be considered as well on the need for ADT with salvage radiation. See the complete post here,
https://www.inspire.com/groups/zero-prostate-cancer/discussion/bda128-adt-and-salvage-radiation-after-surgery/

Jump to this post

@wwsmith
Thanks so much for your input case and attaching this link < 3

REPLY
Profile picture for wwsmith @wwsmith

@jeffmarc Just saw a post on the Inspire forum where a patient with Gleason 4+5 and Decipher 0.98 consulted with Dr. Kishan who was involved in the POSEIDON study the ASCO recommendations about ADT were based on. Dr. Kishan noted that the POSEIDON study pertained to a general post-surgery population (i.e., all Gleason scores), whereas high Gleason scores are important in the decision making for the use of ADT. Also, for that study, men's Decipher scores were unknown and/or not used although high Decipher scores should be considered as well on the need for ADT with salvage radiation. See the complete post here,
https://www.inspire.com/groups/zero-prostate-cancer/discussion/bda128-adt-and-salvage-radiation-after-surgery/

Jump to this post

@wwsmith
It seems the complete Post is actually here
https://www.urotoday.com/video-lectures/asco-gu-2026/video/5413-poseidon-meta-analysis-re-examines-the-role-of-adt-with-salvage-radiation-for-prostate-cancer-amar-kishan.html
In this particular case, the PSA went from .3 to .7 in 18 months. That’s not a very fast, doubling rate. The article does say ADT over .5 for a short term does make sense. I know in my case I only had .2 and I got A six month ADT shot. I didn’t even notice the side effects back then, But it reoccurred in 2 1/2 years And I had to go back on ADT full-time.

When the doubling rate is so slow, they might even consider not doing the ADT. I would let a doctor make that decision.

Interesting article though.

REPLY
Profile picture for jeff Marchi @jeffmarc

@wwsmith
It seems the complete Post is actually here
https://www.urotoday.com/video-lectures/asco-gu-2026/video/5413-poseidon-meta-analysis-re-examines-the-role-of-adt-with-salvage-radiation-for-prostate-cancer-amar-kishan.html
In this particular case, the PSA went from .3 to .7 in 18 months. That’s not a very fast, doubling rate. The article does say ADT over .5 for a short term does make sense. I know in my case I only had .2 and I got A six month ADT shot. I didn’t even notice the side effects back then, But it reoccurred in 2 1/2 years And I had to go back on ADT full-time.

When the doubling rate is so slow, they might even consider not doing the ADT. I would let a doctor make that decision.

Interesting article though.

Jump to this post

@jeffmarc Yes, a full discussion of the POSEIDON trial is at the link you gave. But what I was trying to emphasize was that the article does not mention that high Gleason and Decipher scores should also be considered on the decision about whether ADT is needed or not with salvage radiation. And yet, when a former patient of Dr. Kishan with high Gleason scores and a high Decipher score contacts Dr. Kishan about whether ADT is needed for his case even when his current PSA is less than 0.5, Dr. Kishan readily advises this patient that high Gleason and Decipher scores should always be factored in on whether ADT is needed or not for salvage radiation. Sure wish the recommendation on consideration of high Gleason and Decipher scores was actually mentioned in the POSEIDON article.

REPLY
Profile picture for wwsmith @wwsmith

@jeffmarc Yes, a full discussion of the POSEIDON trial is at the link you gave. But what I was trying to emphasize was that the article does not mention that high Gleason and Decipher scores should also be considered on the decision about whether ADT is needed or not with salvage radiation. And yet, when a former patient of Dr. Kishan with high Gleason scores and a high Decipher score contacts Dr. Kishan about whether ADT is needed for his case even when his current PSA is less than 0.5, Dr. Kishan readily advises this patient that high Gleason and Decipher scores should always be factored in on whether ADT is needed or not for salvage radiation. Sure wish the recommendation on consideration of high Gleason and Decipher scores was actually mentioned in the POSEIDON article.

Jump to this post

@wwsmith
As you say when somebody has an Aggressive case of prostate cancer reoccurrence can be a real problem and ADT can almost be essential. Not only that but an ARPI should normally be prescribed.

REPLY
Profile picture for wwsmith @wwsmith

@jeffmarc Yes, a full discussion of the POSEIDON trial is at the link you gave. But what I was trying to emphasize was that the article does not mention that high Gleason and Decipher scores should also be considered on the decision about whether ADT is needed or not with salvage radiation. And yet, when a former patient of Dr. Kishan with high Gleason scores and a high Decipher score contacts Dr. Kishan about whether ADT is needed for his case even when his current PSA is less than 0.5, Dr. Kishan readily advises this patient that high Gleason and Decipher scores should always be factored in on whether ADT is needed or not for salvage radiation. Sure wish the recommendation on consideration of high Gleason and Decipher scores was actually mentioned in the POSEIDON article.

Jump to this post

@wwsmith He does say, however, that many of those enrolled in the study ( 17 yr span) pre-dated Decipher testing; so that ADT may have been of benefit to them if their scores ‘would have been’ higher had the test been available.
So going forward they can now use Decipher to see which men might derive the greatest benefit.
Also, if you read the comparisons, men on ADT with PSA < 0.5 had no better overall survival , but did have better ‘metastasis free’ survival. So even if 2 men both survived 10 years, perhaps the one who did not receive ADT suffered years of treatment with hormones/chemo/SBRT….but they don’t break that down. Good article.
Phil

REPLY
Please sign in or register to post a reply.